Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1807 entries
Sorted by: Best Match Show Resources per page
Is mild endometriosis always a disease?.

Human reproduction (Oxford, England)

Vercellini P, Bocciolone L, Crosignani PG.
PMID: 1639981
Hum Reprod. 1992 May;7(5):627-9. doi: 10.1093/oxfordjournals.humrep.a137709.

The easy access to the pelvis via laparoscopy has led to an appreciable increase in the diagnosis of endometriosis in women with infertility or chronic pelvic pain. This could suggest a rising incidence of the disease but is probably...

Cite
Vercellini P, Bocciolone L, Crosignani PG. Is mild endometriosis always a disease?. Hum Reprod. 1992;7(5):627-9doi: 10.1093/oxfordjournals.humrep.a137709.
Vercellini, P., Bocciolone, L., & Crosignani, P. G. (1992). Is mild endometriosis always a disease?. Human reproduction (Oxford, England), 7(5), 627-9. https://doi.org/10.1093/oxfordjournals.humrep.a137709
Vercellini, P, et al. "Is mild endometriosis always a disease?." Human reproduction (Oxford, England) vol. 7,5 (1992): 627-9. doi: https://doi.org/10.1093/oxfordjournals.humrep.a137709
Vercellini P, Bocciolone L, Crosignani PG. Is mild endometriosis always a disease?. Hum Reprod. 1992 May;7(5):627-9. doi: 10.1093/oxfordjournals.humrep.a137709. PMID: 1639981.
Copy Download .nbib Format: NLM
Predictive value of early serum beta-human chorionic gonadotrophin for the successful outcome in women undergoing in vitro fertilization.

Journal of human reproductive sciences

Singh N, Goyal M, Malhotra N, Tiwari A, Badiger S.
PMID: 24672163
J Hum Reprod Sci. 2013 Oct;6(4):245-7. doi: 10.4103/0974-1208.126291.

AIMS: Pregnancies achieved by in vitro fertilization (IVF) are at increased risk of adverse outcome. The main objective of this study was to evaluate the predictive value of β-human chorionic gonadotrophin (β-HCG) and age of the patient for the...

Cite
Singh N, Goyal M, Malhotra N, et al. Predictive value of early serum beta-human chorionic gonadotrophin for the successful outcome in women undergoing in vitro fertilization. J Hum Reprod Sci. 2013;6(4):245-7doi: 10.4103/0974-1208.126291.
Singh, N., Goyal, M., Malhotra, N., Tiwari, A., & Badiger, S. (2013). Predictive value of early serum beta-human chorionic gonadotrophin for the successful outcome in women undergoing in vitro fertilization. Journal of human reproductive sciences, 6(4), 245-7. https://doi.org/10.4103/0974-1208.126291
Singh, Neeta, et al. "Predictive value of early serum beta-human chorionic gonadotrophin for the successful outcome in women undergoing in vitro fertilization." Journal of human reproductive sciences vol. 6,4 (2013): 245-7. doi: https://doi.org/10.4103/0974-1208.126291
Singh N, Goyal M, Malhotra N, Tiwari A, Badiger S. Predictive value of early serum beta-human chorionic gonadotrophin for the successful outcome in women undergoing in vitro fertilization. J Hum Reprod Sci. 2013 Oct;6(4):245-7. doi: 10.4103/0974-1208.126291. PMID: 24672163; PMCID: PMC3963307.
Copy Download .nbib Format: NLM
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.

Human reproduction (Oxford, England)

Tournaye H, Sukhikh GT, Kahler E, Griesinger G.
PMID: 28938733
Hum Reprod. 2017 Oct 01;32(10):2152. doi: 10.1093/humrep/dex266.

No abstract available.

Cite
Tournaye H, Sukhikh GT, Kahler E, et al. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017;32(10):2152doi: 10.1093/humrep/dex266.
Tournaye, H., Sukhikh, G. T., Kahler, E., & Griesinger, G. (2017). A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Human reproduction (Oxford, England), 32(10), 2152. https://doi.org/10.1093/humrep/dex266
Tournaye, Herman, et al. "A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization." Human reproduction (Oxford, England) vol. 32,10 (2017): 2152. doi: https://doi.org/10.1093/humrep/dex266
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017 Oct 01;32(10):2152. doi: 10.1093/humrep/dex266. PMID: 28938733; PMCID: PMC6790500.
Copy Download .nbib Format: NLM
Does the type of culture medium used influence birthweight of children born after IVF?.

Human reproduction (Oxford, England)

Zandstra H, Van Montfoort AP, Dumoulin JC.
PMID: 26342017
Hum Reprod. 2015 Nov;30(11):2693. doi: 10.1093/humrep/dev215. Epub 2015 Sep 04.

No abstract available.

Cite
Zandstra H, Van Montfoort AP, Dumoulin JC. Does the type of culture medium used influence birthweight of children born after IVF?. Hum Reprod. 2015;30(11):2693doi: 10.1093/humrep/dev215.
Zandstra, H., Van Montfoort, A. P., & Dumoulin, J. C. (2015). Does the type of culture medium used influence birthweight of children born after IVF?. Human reproduction (Oxford, England), 30(11), 2693. https://doi.org/10.1093/humrep/dev215
Zandstra, Heleen, et al. "Does the type of culture medium used influence birthweight of children born after IVF?." Human reproduction (Oxford, England) vol. 30,11 (2015): 2693. doi: https://doi.org/10.1093/humrep/dev215
Zandstra H, Van Montfoort AP, Dumoulin JC. Does the type of culture medium used influence birthweight of children born after IVF?. Hum Reprod. 2015 Nov;30(11):2693. doi: 10.1093/humrep/dev215. Epub 2015 Sep 04. PMID: 26342017.
Copy Download .nbib Format: NLM
Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome.

Journal of human reproductive sciences

Alvarez AM, Neubeck S, Parra S, Markert UR, Cadavid AP.
PMID: 28479750
J Hum Reprod Sci. 2017 Jan-Mar;10(1):10-17. doi: 10.4103/0974-1208.204018.

CONTEXT: Antiphospholipid antibodies (aPL) are related with a high risk of pregnancy morbidity (PM) and also of vascular thrombosis. On the basis of recent studies, we expect that in women with PM associated with antiphospholipid syndrome (APS), further factors...

Cite
Alvarez AM, Neubeck S, Parra S, et al. Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome. J Hum Reprod Sci. 2017;10(1):10-17doi: 10.4103/0974-1208.204018.
Alvarez, A. M., Neubeck, S., Parra, S., Markert, U. R., & Cadavid, A. P. (2017). Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome. Journal of human reproductive sciences, 10(1), 10-17. https://doi.org/10.4103/0974-1208.204018
Alvarez, Angela M, et al. "Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome." Journal of human reproductive sciences vol. 10,1 (2017): 10-17. doi: https://doi.org/10.4103/0974-1208.204018
Alvarez AM, Neubeck S, Parra S, Markert UR, Cadavid AP. Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome. J Hum Reprod Sci. 2017 Jan-Mar;10(1):10-17. doi: 10.4103/0974-1208.204018. PMID: 28479750; PMCID: PMC5405641.
Copy Download .nbib Format: NLM
Activation of the aryl hydrocarbon receptor by a component of cigarette smoke reduces germ cell proliferation in the human fetal ovary.

Molecular human reproduction

Anderson RA, McIlwain L, Coutts S, Kinnell HL, Fowler PA, Childs AJ.
PMID: 26310844
Mol Hum Reprod. 2015 Sep;21(9):753. doi: 10.1093/molehr/gav044.

No abstract available.

Cite
Anderson RA, McIlwain L, Coutts S, et al. Activation of the aryl hydrocarbon receptor by a component of cigarette smoke reduces germ cell proliferation in the human fetal ovary. Mol Hum Reprod. 2015;21(9):753doi: 10.1093/molehr/gav044.
Anderson, R. A., McIlwain, L., Coutts, S., Kinnell, H. L., Fowler, P. A., & Childs, A. J. (2015). Activation of the aryl hydrocarbon receptor by a component of cigarette smoke reduces germ cell proliferation in the human fetal ovary. Molecular human reproduction, 21(9), 753. https://doi.org/10.1093/molehr/gav044
Anderson, Richard A, et al. "Activation of the aryl hydrocarbon receptor by a component of cigarette smoke reduces germ cell proliferation in the human fetal ovary." Molecular human reproduction vol. 21,9 (2015): 753. doi: https://doi.org/10.1093/molehr/gav044
Anderson RA, McIlwain L, Coutts S, Kinnell HL, Fowler PA, Childs AJ. Activation of the aryl hydrocarbon receptor by a component of cigarette smoke reduces germ cell proliferation in the human fetal ovary. Mol Hum Reprod. 2015 Sep;21(9):753. doi: 10.1093/molehr/gav044. PMID: 26310844; PMCID: PMC4550542.
Copy Download .nbib Format: NLM
Role of Embryo Glue as a transfer medium in the outcome of fresh non-donor in-vitro fertilization cycles.

Journal of human reproductive sciences

Singh N, Gupta M, Kriplani A, Vanamail P.
PMID: 26752856
J Hum Reprod Sci. 2015 Oct-Dec;8(4):214-7. doi: 10.4103/0974-1208.170398.

BACKGROUND: EmbryoGlue is a hyaluronan-enriched embryo transfer (ET) medium which aids in implantation of embryos, hence, improves pregnancy rates in in-vitro fertilization-ET cycles (IVF-ET).AIM: To evaluate the role of EmbryoGlue in improving implantation and pregnancy rates.DESIGN AND SETTING: A...

Cite
Singh N, Gupta M, Kriplani A, et al. Role of Embryo Glue as a transfer medium in the outcome of fresh non-donor in-vitro fertilization cycles. J Hum Reprod Sci. 2015;8(4):214-7doi: 10.4103/0974-1208.170398.
Singh, N., Gupta, M., Kriplani, A., & Vanamail, P. (2015). Role of Embryo Glue as a transfer medium in the outcome of fresh non-donor in-vitro fertilization cycles. Journal of human reproductive sciences, 8(4), 214-7. https://doi.org/10.4103/0974-1208.170398
Singh, Neeta, et al. "Role of Embryo Glue as a transfer medium in the outcome of fresh non-donor in-vitro fertilization cycles." Journal of human reproductive sciences vol. 8,4 (2015): 214-7. doi: https://doi.org/10.4103/0974-1208.170398
Singh N, Gupta M, Kriplani A, Vanamail P. Role of Embryo Glue as a transfer medium in the outcome of fresh non-donor in-vitro fertilization cycles. J Hum Reprod Sci. 2015 Oct-Dec;8(4):214-7. doi: 10.4103/0974-1208.170398. PMID: 26752856; PMCID: PMC4691973.
Copy Download .nbib Format: NLM
Trends of male factor infertility, an important cause of infertility: A review of literature.

Journal of human reproductive sciences

Kumar N, Singh AK.
PMID: 26752853
J Hum Reprod Sci. 2015 Oct-Dec;8(4):191-6. doi: 10.4103/0974-1208.170370.

Infertility and problems of impaired fecundity have been a concern through ages and is also a significant clinical problem today, which affects 8-12% of couples worldwide. Of all infertility cases, approximately 40-50% is due to "male factor" infertility and...

Cite
Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci. 2015;8(4):191-6doi: 10.4103/0974-1208.170370.
Kumar, N., & Singh, A. K. (2015). Trends of male factor infertility, an important cause of infertility: A review of literature. Journal of human reproductive sciences, 8(4), 191-6. https://doi.org/10.4103/0974-1208.170370
Kumar, Naina, and Singh, Amit Kant. "Trends of male factor infertility, an important cause of infertility: A review of literature." Journal of human reproductive sciences vol. 8,4 (2015): 191-6. doi: https://doi.org/10.4103/0974-1208.170370
Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci. 2015 Oct-Dec;8(4):191-6. doi: 10.4103/0974-1208.170370. PMID: 26752853; PMCID: PMC4691969.
Copy Download .nbib Format: NLM
Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women.

Journal of human reproductive sciences

Sharma S, Majumdar A.
PMID: 26752855
J Hum Reprod Sci. 2015 Oct-Dec;8(4):202-8. doi: 10.4103/0974-1208.170394.

MAIN OUTCOME MEASURES: Subjects with and without PCOs were compared with each other for the prevalence of MBS, and similarly team subjects were compared with obese subjects. Receiver operator characteristic (ROC) curves were obtained for both the PCOS and...

Cite
Sharma S, Majumdar A. Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women. J Hum Reprod Sci. 2015;8(4):202-8doi: 10.4103/0974-1208.170394.
Sharma, S., & Majumdar, A. (2015). Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women. Journal of human reproductive sciences, 8(4), 202-8. https://doi.org/10.4103/0974-1208.170394
Sharma, Sangita, and Majumdar, Abha. "Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women." Journal of human reproductive sciences vol. 8,4 (2015): 202-8. doi: https://doi.org/10.4103/0974-1208.170394
Sharma S, Majumdar A. Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women. J Hum Reprod Sci. 2015 Oct-Dec;8(4):202-8. doi: 10.4103/0974-1208.170394. PMID: 26752855; PMCID: PMC4691971.
Copy Download .nbib Format: NLM
From the Editor's desk.

Journal of human reproductive sciences

Patil M.
PMID: 26538852
J Hum Reprod Sci. 2015 Jul-Sep;8(3):119-20. doi: 10.4103/0974-1208.165146.

No abstract available.

Cite
Patil M. From the Editor's desk. J Hum Reprod Sci. 2015;8(3):119-20doi: 10.4103/0974-1208.165146.
Patil, M. (2015). From the Editor's desk. Journal of human reproductive sciences, 8(3), 119-20. https://doi.org/10.4103/0974-1208.165146
Patil, Madhuri. "From the Editor's desk." Journal of human reproductive sciences vol. 8,3 (2015): 119-20. doi: https://doi.org/10.4103/0974-1208.165146
Patil M. From the Editor's desk. J Hum Reprod Sci. 2015 Jul-Sep;8(3):119-20. doi: 10.4103/0974-1208.165146. PMID: 26538852; PMCID: PMC4601168.
Copy Download .nbib Format: NLM
Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism.

Journal of human reproductive sciences

Pandurangi M, Tamizharasi M, Reddy NS.
PMID: 26538857
J Hum Reprod Sci. 2015 Jul-Sep;8(3):146-50. doi: 10.4103/0974-1208.165141.

CONTEXT: Ovulation induction in patients with hypogonadotropic hypogonadism (HH) is a challenge to the treating physician. The threshold for ovarian response in HH may differ substantially from that of normal patients. To reach that threshold levels of follicle stimulating...

Cite
Pandurangi M, Tamizharasi M, Reddy NS. Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism. J Hum Reprod Sci. 2015;8(3):146-50doi: 10.4103/0974-1208.165141.
Pandurangi, M., Tamizharasi, M., & Reddy, N. S. (2015). Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism. Journal of human reproductive sciences, 8(3), 146-50. https://doi.org/10.4103/0974-1208.165141
Pandurangi, Monna, et al. "Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism." Journal of human reproductive sciences vol. 8,3 (2015): 146-50. doi: https://doi.org/10.4103/0974-1208.165141
Pandurangi M, Tamizharasi M, Reddy NS. Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism. J Hum Reprod Sci. 2015 Jul-Sep;8(3):146-50. doi: 10.4103/0974-1208.165141. PMID: 26538857; PMCID: PMC4601173.
Copy Download .nbib Format: NLM
Fertility preservation in female cancer patients: An overview.

Journal of human reproductive sciences

Mahajan N.
PMID: 25838742
J Hum Reprod Sci. 2015 Jan-Mar;8(1):3-13. doi: 10.4103/0974-1208.153119.

Fertility preservation is becoming increasingly important to improve the quality of life in cancer survivors. Despite guidelines suggesting that discussion of fertility preservation should be done prior to starting cancer therapies, there is a lack of implementation in this...

Cite
Mahajan N. Fertility preservation in female cancer patients: An overview. J Hum Reprod Sci. 2015;8(1):3-13doi: 10.4103/0974-1208.153119.
Mahajan, N. (2015). Fertility preservation in female cancer patients: An overview. Journal of human reproductive sciences, 8(1), 3-13. https://doi.org/10.4103/0974-1208.153119
Mahajan, Nalini. "Fertility preservation in female cancer patients: An overview." Journal of human reproductive sciences vol. 8,1 (2015): 3-13. doi: https://doi.org/10.4103/0974-1208.153119
Mahajan N. Fertility preservation in female cancer patients: An overview. J Hum Reprod Sci. 2015 Jan-Mar;8(1):3-13. doi: 10.4103/0974-1208.153119. PMID: 25838742; PMCID: PMC4381379.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1807 entries